Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Kordelia Barbullushi
Observed names:
Barbullushi, K.,
K. Barbullushi
Institutions:
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
University Medical Center Hamburg-Eppendorf
Observed institutions:
University of Milan,
Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico,
Azienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda,
University Medical Center Hamburg-Eppendorf
ORCID:
0009-0008-6055-2137
Observed ORCID:
0009-0008-6055-2137
OpenAlex ID:
A5049869778
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID‐19
2020
·
Chiara Cattaneo
, Rosa Daffini
, et al.
·
Cancer
·
84
PDF
Triple-Negative Essential Thrombocythemia: Clinical-Pathological and Molecular Features. A Single-Center Cohort Study
2021
·
Daniele Cattaneo
, Giorgio Alberto Croci
, et al.
·
Frontiers in Oncology
·
45
PDF
Vaccination Therapy for Acute Myeloid Leukemia: Where Do We Stand?
2022
·
Kordelia Barbullushi
, Nicolò Rampi
, et al.
·
Cancers
·
30
PDF
Disease Modeling and Therapeutic Strategies in CMT2A: State of the Art
2019
·
Kordelia Barbullushi
, Elena Abati
, et al.
·
Molecular Neurobiology
·
23
Prognostic and Predictive Models in Myelofibrosis
2024
·
Barbara Mora
, Cristina Bucelli
, et al.
·
Current Hematologic Malignancy Reports
·
22
PDF
Autoimmune Hemolytic Anemia as a Complication of Congenital Anemias. A Case Series and Review of the Literature
2021
·
Irene Motta
, Juri Giannotta
, et al.
·
Journal of Clinical Medicine
·
22
PDF
Clinical, Morphological and Clonal Progression of VEXAS Syndrome in the Context of Myelodysplasia Treated with Azacytidine
2022
·
Marco Manzoni
, Alessandro Bosi
, et al.
·
Clinical Hematology International
·
18
PDF
Treosulfan, thiotepa and fludarabine conditioning regimen prior to first allogeneic stem cell transplantation in acute myeloid leukemia and high-risk myelodysplastic syndromes: a single center experience
2023
·
G. Cassanello
, F. Serpenti
, et al.
·
Bone Marrow Transplantation
·
9
Co-Occurrence of Myeloid and Lymphoid Neoplasms: Clinical Characterization and Impact on Outcome. A Single-Center Cohort Study
2021
·
Cristina Bucelli
, Bruno Fattizzo
, et al.
·
Frontiers in Oncology
·
7
Off-label venetoclax in combination with hypomethylating agents for post-allogeneic stem cell transplant acute myeloid leukemia relapse
2022
·
Fabio Serpenti
, Mariarita Sciumè
, et al.
·
Leukemia & lymphoma/Leukemia and lymphoma
·
5
Outcomes of allogeneic hematopoietic stem cell transplantation from different donor types in primary refractory acute myeloid leukemia: a report from the ALWP of the EBMT
2025
·
Kordelia Barbullushi
, Myriam Labopin
, et al.
·
Bone Marrow Transplantation
·
2
Outcomes of allogeneic transplantation in blast-phase myeloproliferative neoplasms: one-third achieve long-term survival
2026
·
Kordelia Barbullushi
, Nico Gagelmann
, et al.
·
Bone Marrow Transplantation
·
1
PDF
GVHD in the era of checkpoint inhibition in Hodgkin lymphoma
2025
·
Cecilia Anna Fidanza
, Fabio Serpenti
, et al.
·
Blood Advances
·
1
Early Tapering of Immunosuppression in MRD Positive Myelofibrosis Patients Induces Molecular Response and Excellent Outcome after Hematopoietic Stem Cell Transplantation
2024
·
Kristin Rathje
, Kordelia Barbullushi
, et al.
·
Blood
·
1
PDF
PB0500 Edoxaban for Acute and Long-Term Treatment of Venous Thromboembolism: Real-Life Data from a Single Center Cohort Study
2023
·
M. Abbattista
, M. Capecchi
, et al.
·
Research and Practice in Thrombosis and Haemostasis
·
1
Allogeneic Hematopoietic Cell Transplantation in Advanced Phase Mycosis Fungoides and Sézary Syndrome: A Retrospective Analysis of 57 Consecutive Patients
2022
·
Francesca Cavallaro
, Francesco Versino
, et al.
·
Blood
·
1
Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation from Different Donor Types in Primary Refractory Acute Myeloid Leukemia: A Report from the ALWP of the EBMT
2022
·
Kordelia Barbullushi
, Myriam Labopin
, et al.
·
Blood
·
1
RNAi/gene therapy combined approach as therapeutic strategy for Charcot-Marie-Tooth 2A (S58.005)
2019
·
Federica Rizzo
, Silvia Bono
, et al.
·
Neurology
·
1
Donor lymphocyte infusions as pre-emptive and therapeutic strategy for post-transplant acute lymphoblastic leukemia relapse: A retrospective single-center analysis on 16 consecutive patients
2026
·
Fabio Serpenti
, Cecilia Anna Fidanza
, et al.
·
Annals of Hematology
Danazol treatment for poor graft function after hematopoietic stem cell transplantation: a single centre experience
2025
·
Fabio Serpenti
, Nicole Galli
, et al.
·
Bone Marrow Transplantation
Post-Transplant Lymphoproliferative Disorders (PTLD) in a Referral Center
2024
·
Nicolò Rampi
, Alessandro Bosi
, et al.
·
Blood
PDF
Donor Lymphocyte Infusions in Acute Lymphoblastic Leukemia: A Single-Center Retrospective Analysis
2024
·
Fabio Serpenti
, Cecilia Anna Fidanza
, et al.
·
Blood
PDF
Allogeneic hematopoietic stem cell transplantation in patients with advanced mycosis fungoides and Sézary syndrome: 2023 update of the Milan experience
2023
·
Francesco Onida
, Francesca Cavallaro
, et al.
·
European Journal of Cancer
Show more works
View as search
Works count:
25
Citation count:
274
H-index:
8
I10-index:
7
Year
Topic
Type